News RSS Bioethics News.


Calimmune Initiates HIV Stem Cell Study at Two California Research Sites

External Link - Source:

The HIV gene medicines company Calimmune announced today that the first patient has begun treatment in a Phase I/II clinical trial designed to determine whether a pioneering genetic medicine approach can help to protect individuals infected with HIV.

This entry was posted in Genetics, HIV/AIDS, Stem Cells and tagged , , . Bookmark the permalink.